Duke Clinical Research Institute, Durham, NC.
Circulation. 2013 Sep 10;128(11):1206-13. doi: 10.1161/CIRCULATIONAHA.113.004569. Epub 2013 Aug 14.
Hospital readmission rates within 30 days after acute myocardial infarction are a national performance metric. Previous data suggest that early physician follow-up after heart failure hospitalizations can reduce readmissions; whether these results can be extended to acute myocardial infarction is unclear.
We analyzed data from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) Registry linked with Medicare claims from 2003 to 2006 for 25 872 non-ST-segment-elevation myocardial infarction patients ≥65 years of age discharged home from 228 hospitals with >25 patients and full revascularization capabilities. After adjusting for patient, treatment, and hospital characteristics, we examined the relationship between hospital-level physician follow-up within 7 days of discharge and 30-day all-cause readmission using logistic regression. The median hospital-level percentage of patients receiving early physician follow-up was 23.3% (interquartile range, 17.1%-29.1%). Among 24 165 patients with Medicare fee-for-service eligibility 30 days after discharge, 18.5% of patients were readmitted within 30 days of index hospitalization. Unadjusted and adjusted rates of 30-day readmission did not differ among quartiles of hospital-level early physician follow-up. Similarly, each 5% increase in hospital early follow-up was associated with an insignificant change in risk for readmission (adjusted odds ratio, 0.99; 95% confidence interval, 0.97-1.02; P=0.60). Sensitivity analyses extended these null findings to 30-day cardiovascular readmissions, high-risk subgroups, and early cardiology follow-up.
Although rates of early physician follow-up after acute myocardial infarction varied among US hospitals, hospitals with higher early follow-up rates did not have lower 30-day readmission rates. Targeting strategies other than early physician follow-up may be necessary to reduce readmissions in this population.
急性心肌梗死(AMI)后 30 天内的住院再入院率是一个全国性的绩效指标。先前的数据表明,心力衰竭住院后早期医生随访可以降低再入院率;但这些结果是否可以扩展到急性心肌梗死尚不清楚。
我们分析了 2003 年至 2006 年期间,来自 228 家医院的 25872 名年龄≥65 岁的非 ST 段抬高型心肌梗死(NSTEMI)患者出院后在 Medicare 索赔中与 Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines(CRUSADE)登记相关的数据。在调整了患者、治疗和医院特征后,我们使用逻辑回归分析了出院后 7 天内医院层面医生随访与 30 天全因再入院之间的关系。医院层面接受早期医生随访的患者中位数百分比为 23.3%(四分位距 17.1%-29.1%)。在出院后 30 天有 Medicare 按服务收费资格的 24165 名患者中,18.5%的患者在指数住院后 30 天内再次入院。未经调整和调整后的医院层面早期医生随访 quartile 之间的 30 天再入院率没有差异。同样,医院早期随访增加 5%,再入院风险变化不显著(调整后的比值比,0.99;95%置信区间,0.97-1.02;P=0.60)。敏感性分析将这些无效发现扩展到 30 天心血管再入院、高危亚组和早期心脏病学随访。
尽管美国医院之间急性心肌梗死后早期医生随访的比率有所不同,但早期随访率较高的医院 30 天内再入院率并没有降低。在这一人群中,可能需要针对除早期医生随访以外的策略来降低再入院率。